Public Notice on the Selection Result of the Sub-Fund for Nanjing Zijin Biomedical Industry Investment Fund Partnership (Limited Partnership)
On October 22, 2025, Nanjing Zijin Biomedical Industry Investment Fund Partnership (Limited Partnership) (hereinafter referred to as the "Biomedical FoF") held the second meeting of its Sub-Fund Investment Decision-Making Committee. The meeting reviewed and approved the sub-fund that the Biomedical FoF intends to invest in, with details as follows:
Nanjing Boyuan Jingcheng Phase III Equity Investment Partnership (Limited Partnership) (Provisional Name)
Target Fund Size: RMB 1.5 billion
Registered Location: Jiangbei New Area, Nanjing
Duration: 8 years
Key Investment Areas: Biomedical, medical device & diagnostics, medical +, and bio + fields
In accordance with the requirements specified in the Announcement on the Selection of Managers for the Proposed Sub-Funds of the FoF, after going through processes including institutional application, preliminary document review, due diligence, expert evaluation, and investment decision-making, the proposed sub-fund to be invested in (listed in the attachment) is hereby publicly notified.
Public Notice Period: 5 working days, from October 27, 2025, to October 31, 2025.
Any entity or individual with objections to the public notice result shall submit the objection in writing within the public notice period, along with the reasons for the objection and relevant supporting materials.
For objections submitted in the name of an entity: The objection materials must be affixed with the official seal of the entity.
For objections submitted in the name of an individual: The individual shall provide their real name, affiliation, contact address, and contact information, and sign the objection materials.
To ensure the objectivity, fairness, impartiality, and timeliness of objection handling, anonymous objections or those submitted beyond the public notice period will not be accepted.
Contact Person: Mr. Zhou
Contact Phone: 025-86596544
Contact Email: selection@njicg.com
Contact Address: 41F, Building 4, Financial City, Jianye District, Nanjing, Jiangsu Province
List of Proposed Sub-Funds to Be Invested in by the Biomedical FoF
Source: Nanjing Innovation and Venture Capital Group
Review: Xue Yao
Release: You Yi
